680
Participants
Start Date
March 30, 2016
Primary Completion Date
December 30, 2023
Study Completion Date
December 31, 2025
Goserelin
Tamoxifen
Aromatase Inhibitors
Leuprolide
ACTIVE_NOT_RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
ACTIVE_NOT_RECRUITING
Peking University First Hospital, Beijing
RECRUITING
Dongguan People's Hospital, Dongguan
RECRUITING
GuangDong Hospital Of Traditional Chinese Medicine, Guangzhou
ACTIVE_NOT_RECRUITING
Guangdong People's Hospital, Guangzhou
RECRUITING
Guangdong Provincial Women and Children's Hospital, Guangzhou
RECRUITING
Guangzhou First Municipal People's Hospital, Guangzhou
RECRUITING
Guangzhou Women and Childrens Medical Center, Guangzhou
RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
RECRUITING
Guilin TCMhospital of China, Guilin
ACTIVE_NOT_RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
ACTIVE_NOT_RECRUITING
Yunnan Cancer Hospital, Kunming
RECRUITING
Maoming People's Hospital, Maoming
RECRUITING
The first Affiliated Hospital of Guangxi Medical University, Nanning
ACTIVE_NOT_RECRUITING
The Affiliated Hospital of Qingdao University, Qingdao
ACTIVE_NOT_RECRUITING
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
RECRUITING
Affiliated hospital of Guangdong Medicine College, Zhanjiang
RECRUITING
Affiliated hospital of Guangdong Medicine College, Zhanjiang
RECRUITING
Lian Jiang People' s Hospital, Zhanjiang
ACTIVE_NOT_RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Zhongshan People's Hospital, Zhongshan
RECRUITING
The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai
First Affiliated Hospital, Sun Yat-Sen University
OTHER